Overview
- Amama formally declined the Andalusian health service’s request for information, citing data‑protection and professional secrecy, and argued the SAS alone must verify screening failures.
- The Junta said it sought only aggregated or contextual information rather than identifiable clinical data and dismissed the association’s reply as a public narrative rather than a legal argument.
- Amama’s president clarified that the oft‑quoted figure of more than 4,000 referred to calls and consultations received, not confirmed cases.
- The association now cites roughly 261 women affected who developed cancer and says three deaths are linked to delays, while noting a portion of those cases may ultimately not be cancer.
- The SAS maintains 2,317 BI‑RADS 3 cases are under review with most tied to Hospital Virgen del Rocío and targets completing checks by November 30, as Amama readies about 260 compensation claims with around 50 already filed.